JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zabel, U.
Right arrow Articles by Schmidt, H. H. H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zabel, U.
Right arrow Articles by Schmidt, H. H. H. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 26, 18149-18152, June 25, 1999

COMMUNICATION
Homodimerization of Soluble Guanylyl Cyclase Subunits
DIMERIZATION ANALYSIS USING A GLUTATHIONE S-TRANSFERASE AFFINITY TAG*

Ulrike ZabelDagger , Christoph Häusler, Monika Weeger, and Harald H. H. W. Schmidt

From the Department of Pharmacology and Toxicology, Julius-Maximilians-University, D-97078 Wuerzburg, Germany

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Soluble guanylyl cyclase (sGC) is an alpha /beta -heterodimeric hemoprotein that, upon interaction with the intercellular messenger molecule NO, generates cGMP. Although the related family of particulate guanylyl cyclases (pGCs) forms active homodimeric complexes, it is not known whether homodimerization of sGC subunits occurs. We report here the expression in Sf9 cells of glutathione S-transferase-tagged recombinant human sGCalpha 1 and beta 1 subunits, applying a novel and rapid purification method based on GSH-Sepharose affinity chromatography. Surprisingly, in intact Sf9 cells, both homodimeric GSTalpha /alpha and GSTbeta /beta complexes were formed that were catalytically inactive. Upon coexpression of the respective complementary subunits, GSTalpha /beta or GSTbeta /alpha heterodimers were preferentially formed, whereas homodimers were still detectable. When subunits were mixed after expression, e.g. GSTbeta and beta  or GSTalpha and beta , no dimerization was observed. In conclusion, our data suggest the previously unrecognized possibility of a physiological equilibrium between homo- and heterodimeric sGC complexes.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Nitric oxide plays an important role as an intercellular messenger in a great variety of physiological processes (1, 2). To mediate these effects, NO binds to and regulates several proteinaceous and nonproteinaceous cellular targets. The presently best characterized signal-transducing receptor for NO is the heme-containing enzyme soluble guanylyl cyclase (sGC)1 (3-5). Upon binding of NO to the prosthetic heme group, sGC catalyzes the conversion of GTP to cGMP, which in turn regulates various effector proteins, such as protein kinases, phosphodiesterases, and ion channels (6, 7).

Native sGC purifies as a heterodimeric complex composed of a larger alpha  (~80 kDa) and a smaller beta  subunit (~70 kDa) (3, 8). The N-terminal domains of both subunits are essential for the stimulation of the enzyme by NO (9, 10), whereas heme-binding occurs solely in the beta  subunit (11-13). Both the alpha  and beta  subunit contain a C-terminal cyclase homology domain (CHD), which, in analogy to adenylyl cyclases and pGCs, constitutes a bipartite catalytic center by the association of the alpha  and beta  C-terminal domains (4, 14).

Whereas active pGCs are formed by homodimerization, i.e. association of identical CHDs (14), sGC activity depends on heterodimerization. Only the coexpression of alpha  and beta  subunit cDNAs in heterologous expression systems constitutes active sGC (15-17), whereas separate expression of alpha  or beta  subunits yields neither NO-sensitive nor basally active enzyme. Moreover, sGC activity could not be restored by mixing of the expressed subunits (15).

The central parts of sGCalpha and beta  (9) share extensive homologies with each other and with a 43-amino acid sequence in pGC that is essential for homodimerization (18). This prompted us to speculate whether homodimer formation of sGCalpha or sGCbeta may also occur. It is, however, unknown whether alpha /alpha and/or beta /beta homodimers can assemble intracellularly or whether separately expressed sGC subunits stay monomeric in the absence of a complementary subunit. This would prevent the formation of a "two-CHD" catalytic center and thereby explain the lack of cGMP formation.

Using glutathione S-transferase (GST)-tagged recombinant human sGC subunits expressed in a baculovirus expression system, we here present a single-step purification method for recombinant human sGC (rhsGC) and its subunits, which enabled us to analyze the oligomerization behavior of the sGC subunits. Here we demonstrate for the first time the formation of homodimeric yet inactive sGC complexes. The possible physiological implications for regulation of sGC activity in intact cells are discussed.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Materials-- GSH was purchased from Roche Molecular Biochemicals; cell culture materials were from Life Technologies, Inc. (Eggenstein, Germany). All other chemicals were of the highest purity grade available and obtained from either Sigma Chemicals (Deisenhofen, Germany) or Merck AG (Darmstadt, Germany). Water was deionized to 18 MOmega cm (Milli-Q; Millipore, Eschborn, Germany).

Baculovirus Construction-- cDNAs comprising the complete coding sequences for hsGCalpha and beta  subunits (17, 19) were cloned into the pAcG2T baculovirus transfer vector (Pharmingen, San Diego, CA), which allows the expression of GST-sGC fusion proteins and provides a thrombin cleavage site for proteolytic removal of the GST tag. For in-frame cloning, BamHI sites (underlined below) were introduced by polymerase chain reaction immediately upstream of the translational start sites. Fragments were amplified with the primer pairs 5'-AAAAGGATCCATGTTCTGCACGAAGCTC-3' (bp 524-541) and 5'-ATTATGGAAGCAGGGAGG-3' (bp 1249-1232) for alpha 1 and 5'-AAAAGGATCCATGTACGGATTTGTGAAT-3' (bp 89-106) and 5'-ATGCGTGATTCCTGGGTACC-3' (bp 711-692) for beta 1. Products were cut with BamHI/BsaAI (alpha 1) or BamHI/KpnI (beta 1) and ligated with BsaAI/EcoRI (bp 1193-3015, alpha 1) or KpnI/EcoRI (bp 692-2444, beta 1) cDNA fragments to the BamHI/EcoRI-cleaved vector. Recombinant GST-hsGCalpha 1 and GST-hsGCbeta 1 baculoviruses were isolated as described for hsGCalpha 1 and hsGCbeta 1 baculoviruses (17).

Sf9 Cell Culture and Production of rhsGC-- Sf9 cells were cultured as described (17). For expression of nontagged rhsGC subunits, spinner cultures (2 × 106 cells ml-1) were infected with recombinant baculoviruses coding for hsGCalpha 1 or hsGCbeta 1 (17) at a multiplicity of infection (m.o.i.) of 5 plaque-forming units/cell. This high m.o.i. ensured that nearly all cells (>99%) were infected with the viruses encoding the nontagged subunits, which is necessary in the triple expression experiment shown in Fig. 2D (see "Results"). Infections with GST-hsGCalpha and GST-hsGCbeta viruses (see above) were performed at an m.o.i. of 0.5 plaque-forming units/cell, because expression levels of the GST-tagged rhsGC subunits were substantially higher (data not shown). Infection of cells with a baculovirus coding for GST (kind gift from C. Weber, Institut für Medizinische Strahlenkunde und Zellforschung, Würzburg) were performed at a m.o.i. of 2.5 plaque-forming units/cell. Cells were harvested 72 h post infection, and all subsequent procedures were performed at 4 °C. Cells were lysed for 15 min on ice in hypotonic lysis buffer (25 mM triethanolamine, pH 7.8, 1 mM EDTA, 5 mM dithiothreitol, 1 µM leupeptin, 0.5 µg ml-1 soy bean trypsin inhibitor), and crude supernatant and particulate fractions were separated by centrifugation (20,000 × g) for 15 min at 4 °C. Supernatant fractions were brought to a final concentration of 75 mM NaCl; for storage at -20 °C, a final concentration of 10% (v/v) glycerol was used. Protein concentrations were determined according to Bradford (20), using bovine serum albumin as a standard.

GSH-Sepharose Affinity Chromatography-- Glutathione-Sepharose 4B (Amersham Pharmacia Biotech, Freiburg, Germany) was equilibrated with lysis buffer (see above) containing 75 mM NaCl, incubated with crude supernatant fractions of rhsGC-containing Sf9 cells for 1 h at 25 °C in a rotation mixer, and washed two or three times with lysis buffer containing 75 mM NaCl. For GSH elution, GSH-Sepharose was incubated with 5 mM GSH in 50 mM Tris-HCl, pH 8.0, for 5 min at 25 °C. Fractions were brought to a final concentration of 10% (v/v) glycerol and kept at -20 °C.

Size Exclusion Chromatography-- Crude rhsGC-containing Sf9 supernatant fractions were subjected to fast protein liquid chromatography on a Superose 6 column (Amersham Pharmacia Biotech) at a flow rate of 0.2 ml min-1 in 50 mM Tris-HCl, pH 6.7, 300 mM NaCl, 1 mM EDTA and 1 mM dithiothreitol. Aliquots of each fraction were assayed for rhsGC-immunoreactive protein by Western blot. Signals were quantitated by flatbed scanning and densitometry using the NIH Image software (Division of Computer Research and Technology, National Institutes of Health, Bethesda, MD). The column was calibrated with standard proteins (Sigma) of known Stoke's radii: thyroglobulin (8.5 nm), apoferritin (6.1 nm), alcohol dehydrogenase (4.55 nm), bovine serum albumin (3.55 nm), and carbonic anhydrase (2.01 nm).

sGC Activity Assay-- sGC activity was measured as the formation of cGMP at 37 °C for 10 min in a total volume of 100 µl, containing 50 mM triethanolamine HCl, pH 7.4, 3 mM GSH, 1 mM 3-isobutyl-1-methylxanthine, 5 mM creatine phosphate, 0.25 mg ml-1 creatine kinase, 500 µM GTP, and either 3 mM MgCl2 or 3 mM MnCl2. Reactions were started by adding the enzyme-containing fraction and immediately thereafter the sGC activator sodium nitroprusside (100 µM). The cGMP content was determined by an enzyme-linked immunoassay (Biotrend, Cologne, Germany). Results are expressed as the means ± S.E. of at least three experiments.

Western Blot-- Immunodetection of nontagged and GST-tagged rhsGC subunits was performed as described previously (17), using polyclonal antibodies raised against peptide sequences that correspond to hsGCalpha 1 (amino acids 634-647) and hsGCbeta 1 (amino acids 593-614), which were affinity-purified against the respective peptides. Blots were developed using the ECL detection system (Amersham Pharmacia Biotech) according to the manufacturer's protocol.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

To examine sGC subunit association, we established a rapid and efficient method to purify rhsGC and its subunits. Fusion proteins composed of a GST affinity tag (25 kDa), and the recombinant human sGCalpha 1 and beta 1 subunits (rhsGCalpha 1, 79.5 kDa, and rhsGCbeta 1, 68, 5 kDa (17)) were constructed and expressed in the baculovirus/Sf9 cell system.

As shown in Fig. 1A, the recombinant GST-rhsGCalpha 1 and GST-rhsGCbeta 1 (GSTalpha , GSTbeta ) fusion proteins migrated with the expected apparent molecular masses of 105 and 94 kDa, bound to GSH-Sepharose, and were specifically eluted with GSH (lanes 2-5). In contrast, the nontagged rhsGCalpha 1 (alpha ) and rhsGCbeta 1 (beta ) subunits did not bind to the GSH beads (lanes 6-9). In addition to the full-length recombinant proteins, some sGC-immunoreactive degradation products were recognized in crude Sf9 lysates (lanes 2, 4, and 6), which did not appear in lysates from noninfected Sf9 cells (lane 1).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Expression and heterodimerization of GST-tagged and nontagged rhsGCalpha 1 and beta 1 subunits. Crude supernatant fractions of Sf9 cells expressing GST-tagged rhsGCalpha 1 (GSTalpha ), GST-tagged rhsGCbeta 1 (GSTbeta ), nontagged rhsGCalpha 1 (alpha ), and/or beta 1 (beta ) were subjected to GSH-Sepharose affinity chromatography (see "Experimental Procedures"). Load and eluate fractions were analyzed by Western blot, which was developed simultaneously with alpha 1- and beta 1-specific antibodies (see "Experimental Procedures"). A, GSTalpha and GSTbeta specifically bind to GSH-Sepharose. GSTalpha , GSTbeta , alpha , and beta  were expressed separately. Sf9, crude supernatant fraction of noninfected Sf9 cells. B, heterodimerization of GST-tagged rhsGC. GSTalpha and beta  (GSTbeta and alpha ) were coexpressed (lanes 1-4) or mixed after separate expression and incubated for 15 min at room temperature prior to GSH-Sepharose binding (lanes 5-8). L, load; E, GSH eluate.

As shown in Fig. 1B, the GST-tagged sGC subunits retained their ability to heterodimerize with the respective complementary nontagged subunit. When coexpressed in Sf9 cells, nontagged beta  co-eluted with GSTalpha and vice versa (lanes 1-4), indicating a direct physical interaction and demonstrating that addition of the GST tag did apparently not interfere with the dimerization function. Whereas coexpression of GSTalpha and beta  subunits yielded active and NO-sensitive sGC in crude Sf9 cell supernatant fractions, only basal sGC activity was obtained upon coexpression of GSTbeta and alpha  (Table I). Apparently, GST tagging of the sGCbeta N terminus interfered with NO stimulation, probably because of the close proximity of the GST to the heme-binding site (11-13). GSTalpha /beta activity in the presence of Mg2+ was very similar to that of nontagged rhsGC expressed in the same system (17). In the presence of Mn2+, basal sGC activity was increased, whereas NO-stimulated activity was decreased (Table I), as reported for native (21) and recombinant sGC (9). Specific basal sGC activity was dramatically increased in the GSH eluate fraction (Table I), similar to sGCalpha /beta prepared by multi-step purification procedures (8, 22-24). Moreover, NO sensitivity of purified GSTalpha /beta was preserved, because the enzyme was activated 30-fold by 100 µM sodium nitroprusside (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Specific activities of rhsGC dimers
GSTalpha or GSTbeta were coexpressed with alpha  or beta  in Sf9 cells. Basal and sodium nitroprusside (100 µM)-stimulated specific sGC activities were determined in crude Sf9 cell supernatant fractions in the presence of 3 mM Mg2+ or 3 mM Mn2+. sGC activities are given as mean ± S.E. of at least three experiments performed in duplicate. The corresponding stimulation factors are provided (-fold). NA, not applicable.

Heterodimerization of both GSTalpha /beta and GSTbeta /alpha complexes was dependent on coexpression of the respective subunits (Fig. 1B, lanes 5-8). Accordingly, no basal or NO-stimulated sGC activity was detected in the load or eluate fractions derived from separately expressed and mixed GSTalpha and beta  (or GSTbeta and alpha ) subunits (data not shown), which was in agreement with previous findings on nontagged alpha  and beta  subunits (15)

When GSTalpha /alpha and GSTbeta /beta were coexpressed in Sf9 cells, none of the crude cell lysates contained any detectable sGC activity (i.e. <30 pmol cGMP mg-1 min-1; Table I), neither with Mg2+ nor Mn2+. To investigate whether sGC subunits homo-oligomerized, fractions were analyzed by Western blot. Interestingly, nontagged beta  efficiently copurified with GSTbeta , demonstrating a direct physical interaction between sGCbeta subunits (Fig. 2A, lanes 3 and 4). This beta /beta homodimerization was dependent on coexpression of both subunits (lanes 7 and 8). Similarly, the nontagged alpha  subunit copurified with GSTalpha . However, binding of GSTalpha to the GSH-Sepharose was weakened when nontagged alpha  was coexpressed (Fig. 2A, lanes 1 and 2), requiring longer exposure times during Western blot analysis (Fig. 2B, upper panel). In contrast, nontagged alpha , which was expressed separately and mixed with GSTalpha , had no effect on binding of GSTalpha to the beads (Fig. 2A, lanes 5 and 6). This demonstrated that nontagged alpha  interacted with GSTalpha upon coexpression, leading to an interference with binding to GSH-Sepharose, possibly because of steric hindrance. Coelution of alpha  and beta  with the respective GST-tagged subunit did not result from unspecific binding to the GSH-Sepharose, because the wash steps prior to elution did not contain any nontagged sGC (Fig. 2B). Likewise, alpha  and beta  did not coelute with GST alone (Fig. 2C). Therefore, coelution of alpha  with GSTalpha and of beta  with GSTbeta represent specific protein-protein interactions of identical rhsGC subunits.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Homodimerization of rhsGCalpha 1 and beta 1 subunits. Crude supernatant fractions of Sf9 cells coexpressing GST-tagged and nontagged rhsGC subunits as indicated were subjected to GSH-Sepharose affinity chromatography, and fractions were analyzed as described in the legend to Fig. 1. A, homodimerization of rhsGC subunits is dependent on coexpression. B, GSTalpha and alpha  and GSTbeta and beta  specifically co-elute from GSH-Sepharose. C, rhsGCalpha 1 and beta 1 do not interact with GST. Crude supernatant fractions of Sf9 cells coexpressing GST and rhsGCalpha 1 (upper panel) or GST and rhsGCbeta 1 (middle panel) were affinity-purified and analyzed as described in the legend to Fig. 1. rhsGCalpha 1 and rhsGCbeta 1 did not bind to and co-elute with GST (upper and middle panel). GST was specifically eluted with GSH, as shown by Coomassie Blue protein staining (lower panel). D, formation of heterodimeric rhsGC is preferred in Sf9 cells. GSTalpha , alpha , and beta  (lanes 1 and 2) or GSTbeta , alpha , and beta  (lanes 3 and 4) were coexpressed (see "Experimental Procedures"), and crude supernatant fractions were affinity-purified and analyzed as described in the legend to Fig. 1. L, load (crude Sf9 supernatant fraction); SN, supernatant of GSH beads; W1, W2, and W3, wash fractions; E, E1, and E2), GSH eluate.

To analyze whether single rhsGC subunits form dimeric (as does alpha /beta ) or multimeric complexes, crude Sf9 supernatant fractions containing rhsGC were subjected to size exclusion chromatography (Fig. 3). To exclude any potential artifacts caused by the GST tag, nontagged subunits were applied in this set of experiments. As shown in Fig. 3A, coexpressed rhsGCalpha and beta  subunits perfectly co-eluted upon size exclusion chromatography, with a Stoke's radius of 5.3 nm (Fig. 3A, inset). A similar Stoke's radius (4.8 nm) was reported for heterodimeric sGC purified from rat lung (3). Importantly, rhsGCalpha and rhsGCbeta , when expressed separately, showed an elution pattern very similar to heterodimeric sGC (Fig. 3B), suggesting that both subunits indeed exist as homodimers. However, a fraction of rhsGCbeta (<20%) formed aggregates under these conditions (Fig. 3B, fractions 2-6). The peaks of rhsGCalpha and rhsGCbeta were slightly separated, reflecting apparent differences in the Stoke's radii between the alpha /alpha and beta /beta homodimers (Fig. 3B).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Size exclusion chromatography. Crude supernatant fractions of Sf9 cells coexpressing rhsGCalpha 1 and beta 1 (A) or rhsGCalpha 1 or rhsGCbeta 1 (B) were subjected to size exclusion chromatography. Signals from Western blot analysis of fractions were quantitated by densitometry. The inset in A depicts Stoke's radii of protein standards plotted against the respective elution fraction. The Stoke's radius of heterodimeric rhsGC was 5.3 nm. black-square, rhsGCalpha 1 in heterodimeric sGC complexes; , rhsGCbeta 1 in heterodimeric sGC complexes; black-triangle, homodimeric rhsGCalpha 1; triangle , homodimeric rhsGCbeta 1.

To further investigate whether sGC homodimer formation can occur also in the presence of complementary subunits, Sf9 cells were cotransfected with three viruses coding for GSTalpha , alpha , and beta  (or GSTbeta , alpha  and beta ). Viruses coding for alpha  and beta  were applied at a high m.o.i. to ensure that nearly all cells (>99%) expressing GSTalpha (or GSTbeta ) were simultaneously infected with both alpha  and beta  viruses. As shown in Fig. 2D, heterodimer (i.e. GSTbeta /alpha or GSTalpha /beta ), formation is preferred under these conditions in insect cells. However, about 10% of the recombinant protein formed GSTalpha /alpha or GSTbeta /beta complexes even in the presence of the respective complementary subunits. This demonstrated the existence of an equilibrium between homo- and heterodimeric sGC.

Based on these data, sGCalpha and beta  subunits are in fact capable of forming homodimeric complexes in intact Sf9 cells. It has to be clarified whether classical purification methods efficiently remove homodimeric sGC from crude preparations of recombinant sGC or whether apparently homogenous sGC preparations contain "silent" homodimeric sGC. With the novel purification method presented here, only GSTalpha /beta heterodimers will be purified, because beta /beta does not bind to the column.

There are different potential mechanisms that might underlie the observed preferential heterodimer formation in Sf9 cells. Homodimer formation may be suppressed in intact cells because of a much higher affinity between complementary subunits. So far, no data on sGC dimerization kinetics and apparent KD values are available. However, the high stability of homodimeric sGC upon mixing of separately expressed subunits, which seems to be similar to that of heterodimeric sGC, argues against substantial affinity differences. On the other hand, sGC dimerization might be a regulated process in living cells. The existence of at least two different isoforms of each subunit (alpha 1, alpha 2, beta 1, and beta 2) led to the concept that sGC activity is regulated in vivo by alternative heterodimerization (4, 5). It is an intriguing possibility that regulation of sGC activity in vivo might involve not only alternative heterodimerization but also changes in the extent of homodimerization. Based on our data, it cannot be excluded that a further protein is associated with homodimeric sGC complexes, which may be involved in complex formation and therefore be a functional inhibitor of sGC activity. An endogenous inhibitor of sGC has been described in Ref. 25. Interestingly, both homo- and heterodimerization depend on co- or post-translational processes. It has been suggested that chaperone-mediated formation of hetero-oligomeric protein complexes is involved in the regulation of signaling pathways (26). A related process may regulate sGC protein-protein interactions and thus NO/cGMP signaling.

    ACKNOWLEDGEMENTS

We thank Dr. Cornelius Krasel for helpful discussions and Dr. Christoph Weber for providing a baculovirus for GST expression.

    FOOTNOTES

* This work was supported by Deutsche Forschungsgemeinschaft Grant SFB355/C7.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pharmacology and Toxicology, Julius-Maximilians-University, Versbacher Str. 9, D-97078 Wuerzburg, Germany. Tel.: 49-931-201-3992; Fax: 49-931-201-3539; E-mail: medk311{at}rzbox.uni-wuerzburg.de.

    ABBREVIATIONS

The abbreviations used are: sGC, soluble guanylyl cyclase; rhsGC, recombinant human sGC; cGMP, 3',5'-cyclic guanosine monophosphate; CHD, cyclase homology domain; GSH, glutathione; GST, glutathione S-transferase; GSTalpha , GST-tagged rhsGCalpha 1; GSTbeta , GST-tagged rhsGCbeta 1; pGC, particulate guanylyl cyclase; bp, base pairs; m.o.i., multiplicity of infection.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
  1. Schmidt, H. H. H. W., and Walter, U. (1994) Cell 78, 919-925[CrossRef][Medline] [Order article via Infotrieve]
  2. Murad, F. (1996) J. Am. Med. Assoc. 276, 1189-1192[Abstract]
  3. Kamisaki, Y., Saheki, S., Nakane, M., Palmieri, J. A., Kuno, T., Chang, B. Y., Waldman, S. A., and Murad, F. (1986) J. Biol. Chem. 261, 7236-7241[Abstract/Free Full Text]
  4. Koesling, D., Humbert, P., and Schultz, G. (1995) Nitric Oxide in the Nervous System , pp. 43-50, Academic Press, Orlando, FL
  5. Hobbs, A. J. (1997) Trends Pharmacol. Sci. 18, 484-491[Medline] [Order article via Infotrieve]
  6. Schmidt, H. H. H. W., Lohmann, S. M., and Walter, U. (1993) Biochim. Biophys. Acta 1178, 153-175[Medline] [Order article via Infotrieve]
  7. Lincoln, T. M., Cornwell, T. L., Komalavilas, P., Macmillan-Crow, L. A., and Boerth, N. (1996) in Biochemistry of Smooth Muscle Contraction (Barany, M., ed) , pp. 257-268, Academic Press, Orlando, FL
  8. Garbers, D. L. (1979) J. Biol. Chem. 254, 240-243[Abstract/Free Full Text]
  9. Wedel, B., Harteneck, C., Foerster, J., Friebe, A., Schultz, G., and Koesling, D. (1995) J. Biol. Chem. 270, 24871-24875[Abstract/Free Full Text]
  10. Foerster, J., Harteneck, C., Malkewitz, J., Schultz, G., and Koesling, D. (1996) Eur. J. Biochem. 240, 380-386[Medline] [Order article via Infotrieve]
  11. Wedel, B., Humbert, P., Harteneck, C., Foerster, J., Malkewitz, J., Böhme, E., Schultz, G., and Koesling, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2692-2596
  12. Zhao, Y., and Marletta, M. A. (1997) Biochemistry 36, 15959-15964[CrossRef][Medline] [Order article via Infotrieve]
  13. Zhao, Y., Schelvis, J. P. M., Babcock, G. T., and Marletta, M. A. (1998) Biochemistry 37, 4502-4509[CrossRef][Medline] [Order article via Infotrieve]
  14. Garbers, D. L., and Lowe, D. G. (1994) J. Biol. Chem. 269, 30741-30744[Free Full Text]
  15. Harteneck, C., Koesling, D., Söling, A., Schultz, G., and Böhme, E. (1990) FEBS Lett. 272, 221-223[CrossRef][Medline] [Order article via Infotrieve]
  16. Nakane, M., Arai, K., Saheki, S., Kuno, T., Buechler, W., and Murad, F. (1990) J. Biol. Chem. 265, 16841-16845[Abstract/Free Full Text]
  17. Zabel, U., Weeger, M., La, M., and Schmidt, H. H. H. W. (1998) Biochem. J. 335, 51-57
  18. Wilson, E. M., and Chinkers, M. (1995) Biochemistry 34, 4696-4701[CrossRef][Medline] [Order article via Infotrieve]
  19. Giuili, G., Scholl, U., Bulle, F., and Guellaen, G. (1992) FEBS Lett. 304, 83-88[CrossRef][Medline] [Order article via Infotrieve]
  20. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
  21. Waldman, S. A., and Murad, F. (1987) Pharmacol. Rev. 39, 163-196[Medline] [Order article via Infotrieve]
  22. Braughler, J. M., Mittal, C. K., and Murad, F. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 219-222[Abstract/Free Full Text]
  23. Gerzer, R., Hofmann, F., and Schultz, G. (1981) Eur. J. Biochem. 116, 479-486[Medline] [Order article via Infotrieve]
  24. Humbert, P., Niroomand, F., Fischer, G., Mayer, B., Koesling, D., Hinsch, K.-D., Gausepohl, H., Frank, R., Schultz, G., and Böhme, E. (1990) Eur. J. Biochem. 190, 273-278[Medline] [Order article via Infotrieve]
  25. Kim, T. D., and Burstyn, J. N. (1994) J. Biol. Chem. 269, 15540-15545[Abstract/Free Full Text]
  26. Rutherford, S. L., and Zuker, C. S. (1994) Cell 79, 1129-1132[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Ma, N. Sayed, P. Baskaran, A. Beuve, and F. van den Akker
PAS-mediated Dimerization of Soluble Guanylyl Cyclase Revealed by Signal Transduction Histidine Kinase Domain Crystal Structure
J. Biol. Chem., January 11, 2008; 283(2): 1167 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Rothkegel, P. M. Schmidt, D.-J. Atkins, L. S. Hoffmann, H. H. H. W. Schmidt, H. Schroder, and J.-P. Stasch
Dimerization Region of Soluble Guanylate Cyclase Characterized by Bimolecular Fluorescence Complementation in Vivo
Mol. Pharmacol., November 1, 2007; 72(5): 1181 - 1190.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. P. Cabilla, M. d. C. Diaz, L. I. Machiavelli, A. H. Poliandri, F. A. Quinteros, M. Lasaga, and B. H. Duvilanski
17{beta}-Estradiol Modifies Nitric Oxide-Sensitive Guanylyl Cyclase Expression and Down-Regulates Its Activity in Rat Anterior Pituitary Gland
Endocrinology, September 1, 2006; 147(9): 4311 - 4318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. L. Kwak, K. A. Jones, D. O. Warner, and W. J. Perkins
NO responsiveness in pulmonary artery and airway smooth muscle: the role of cGMP regulation
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L200 - L208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Meurer, S. Pioch, S. Gross, and W. Muller-Esterl
Reactive Oxygen Species Induce Tyrosine Phosphorylation of and Src Kinase Recruitment to NO-sensitive Guanylyl Cyclase
J. Biol. Chem., September 30, 2005; 280(39): 33149 - 33156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Wagner, M. Russwurm, R. Jager, A. Friebe, and D. Koesling
Dimerization of Nitric Oxide-sensitive Guanylyl Cyclase Requires the {alpha}1 N Terminus
J. Biol. Chem., May 6, 2005; 280(18): 17687 - 17693.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. O. Melichar, D. Behr-Roussel, U. Zabel, L. O. Uttenthal, J. Rodrigo, A. Rupin, T. J. Verbeuren, A. Kumar H. S., and H. H. H. W. Schmidt
Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis
PNAS, November 23, 2004; 101(47): 16671 - 16676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Meurer, S. Pioch, K. Wagner, W. Muller-Esterl, and S. Gross
AGAP1, a Novel Binding Partner of Nitric Oxide-sensitive Guanylyl Cyclase
J. Biol. Chem., November 19, 2004; 279(47): 49346 - 49354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Zhou, S. Gross, C. Roussos, S. Meurer, W. Muller-Esterl, and A. Papapetropoulos
Structural and Functional Characterization of the Dimerization Region of Soluble Guanylyl Cyclase
J. Biol. Chem., June 11, 2004; 279(24): 24935 - 24943.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Friebe and D. Koesling
Regulation of Nitric Oxide-Sensitive Guanylyl Cyclase
Circ. Res., July 25, 2003; 93(2): 96 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
D. B. Morton and E. J. Anderson
MsGC-{beta}3 forms active homodimers and inactive heterodimers with NO-sensitive soluble guanylyl cyclase subunits
J. Exp. Biol., March 15, 2003; 206(6): 937 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Burette, U. Zabel, R. J. Weinberg, H. H. H. W. Schmidt, and J. G. Valtschanoff
Synaptic Localization of Nitric Oxide Synthase and Soluble Guanylyl Cyclase in the Hippocampus
J. Neurosci., October 15, 2002; 22(20): 8961 - 8970.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Chadli, I. Bouhouche, W. Sullivan, B. Stensgard, N. McMahon, M. G. Catelli, and D. O. Toft
Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90
PNAS, October 23, 2000; (2000) 220430297.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-C. Lee, E. Martin, and F. Murad
Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation
PNAS, September 19, 2000; (2000) 190333697.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
K. A. Lucas, G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik, and S. A. Waldman
Guanylyl Cyclases and Signaling by Cyclic GMP
Pharmacol. Rev., September 1, 2000; 52(3): 375 - 414.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-C. Lee, E. Martin, and F. Murad
Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation
PNAS, September 26, 2000; 97(20): 10763 - 10768.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Chadli, I. Bouhouche, W. Sullivan, B. Stensgard, N. McMahon, M. G. Catelli, and D. O. Toft
Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90
PNAS, November 7, 2000; 97(23): 12524 - 12529.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager